Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

135.88
Delayed Data
As of May 25
 +0.98 / +0.73%
Today’s Change
95.14
Today|||52-Week Range
137.00
+20.59%
Year-to-Date

Today’s Trading

Previous close134.90
Today’s open135.33
Day’s range134.39 - 136.74
Volume282,062
Average volume (3 months)353,891
Market cap$5.9B
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+57.48%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+35.13%
P/E ratio127.0
Price/Sales12.56
Price/Book13.13

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.89+1.30%
WSTWest Pharmaceutical ...+0.85+0.89%
MASIMasimo Corp+1.76+2.05%
NUVANuVasive Inc+2.65+3.62%
Data as of 05/25/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts